Mangsbo SM

Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology.

Laurén I, Havervall S, Ng H, ..., Thålin C, Mangsbo S

Immun Inflamm Dis 10 (4) e595 [2022-04-00; online 2022-03-30]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: High-throughput and high-content serology Research Area: Vaccine Type: Journal article

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Havervall S, Ng H, Jernbom Falk A, ..., Hober S, Thålin C

J Intern Med 291 (1) 72-80 [2022-01-00; online 2021-09-27]

Category: Biochemistry Category: Health Funder: KAW/SciLifeLab National COVID program Research Area: Biobanks for COVID-19 research Research Area: Drug discovery and repurposing of drugs Research Area: High-throughput and high-content serology Research Area: Host cell systems biology and targets Research Area: Viral sequence evolution

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.

Mangsbo SM, Havervall S, Laurén I, ..., Klingström J, Thålin C

PLoS One 16 (9) e0258041 [2021-09-30; online 2021-09-30]

Category: Biochemistry Category: Health Category: Imaging Type: Journal article

Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention

Nasi A, McArdle S, Gaudernack G, ..., Sjölin J, Mangsbo S

Toxicology Reports 7 (-) 768-771 [2020-00-00; online 2020-00-00]

Funder: KAW/SciLifeLab National COVID program Research Area: Drug discovery and repurposing of drugs Type: Review